CARCINOEMBRYONIC ANTIGEN IN THYROID-CANCER

被引：7

作者：

CIMITAN, M ^{[1
]}

BUSNARDO, B ^{[1
]}

GIRELLI, ME ^{[1
]}

CASARA, D ^{[1
]}

ZANATTA, GP ^{[1
]}

机构：

[1] UNIV PADUA,IST SEMEIOT MED,I-35100 PADUA,ITALY

来源：

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 1979年 / 2卷 / 03期

关键词：

carcinoembryonic antigen; follow-up; medullary carcinoma; therapy; Thyroid cancer;

D O I：

10.1007/BF03350409

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Serum levels of carcinoembryonic antigen (CEA) were measured by radioimmunoassay in 35 patients affected by various histological types of thyroid carcinoma: 9 papillary, 7 follicular, 4 undifferentiated, 15 medullary. All patients with nonmedullary thyroid carcinoma were studied preoperatively. No patient with follicular thyroid carcinoma showed CEA levels above normal limits (< 0,5-10 ng/ml). Only 1 out of 9 patients with papillary thyroid carcinoma showed marginally elevated CEA levels (13 ng/ml). Of 4 patients with undifferentiated thyroid carcinoma 1 had high CEA levels (39 ng/ml) and 2 marginally elevated levels (12-13 ng/ml). High CEA levels (>320 ng/ml) were found in 2 of the 4 patients with medullary thyroid carcinoma studied before treatment and in the 4 patients (>320->320- 23-15 ng/ml) studied after total thyroidectomy alone; 3 of them had distant metastases. High levels (65-50-13 ng/ml) were also found in 3 other patients without metastases studied after total thyroidectomy plus radiotherapy. Thyroidectomy plus radiotherapy rapidly decreased CEA levels (from >320 to 20 ng/ml) in a patient without metastases, while the same treatment failed to reduce CEA levels consistently (from > 320 to 112 ng/ml) in a patient with distant metastases. The data suggest than high levels of CEA are frequent but not constant in patients with medullary thyroid carcinoma; in other histological types CEA is present only in sporadic cases. Since in the positive cases of medullary thyroid carcinoma CEA levels seem to be related to the effectiveness of the therapy, CEA assay may be useful in the management and follow up of this tumour. © 1979, Italian Society of Endocrinology (SIE). All rights reserved.

引用

页码：241 / 244

页数：4

共 13 条

[1]

Gold P., Freedman S.O., Demonstration of tumour-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques, J. Exp. Med., 121, (1965)

[2]

Laurence D.J.R., Stevens U., Bettelheim R., Darcy D., Leese C., Turberville C., Alexander P., Johns E.W., Munro Neville A., Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary and bronchial carcinoma, Br. Med. J., 3, (1972)

[3]

Rochman H., DeGroot L.J., Rieger C.H.L., Varnavides L.A., Refetoff S., Joung J.I., Hoye K., Carcinoembryonic antigen and humoral antibody response in patients with thyroid carcinoma, Cancer Res., 35, (1975)

[4]

Ishikawa N., Hamada S., Association of medullary carcinoma of the thyroid with carcinoembryonic antigen, Br. J. Cancer, 34, (1976)

[5]

Economidou J., Karacoulis P., Manousos O.N., Manesis E., Kydonakis A., Koutras D.A., Carcinoembryonic antigen in thyroid disease, J. Clin. Path., 30, (1977)

[6]

Calmettes C., Moukhtar, Milhaud G., Correlation between calcitonin and carcinoembryonic antigen levels in medullary carcinoma of thyroid, Biomedicine, 27, (1977)

[7]

Pages A., Cancer medullaire à stroma amyloide et système endocrinien diffus (S.E.D.), Ann. Endocrinol. (Paris), 35, (1974)

[8]

Hill C.S., Ibanez M.L., Samaan N.A., Ahearn M.J., Clark R.L., Medullary (solid) carcinoma of the thyroid gland: an analysis of the M.D. Anderson Hospital experience with patients with the tumor, its special features, and its histogenesis, Medicine, 52, (1973)

[9]

Willia E.D., Karim S.M.M., Sandler M., Prostaglandin secretion by medullary carcinoma of the thyroid, Lancet, 1, (1968)

[10]

Bigazzi M., Revoltella R., Casciano S., High level of nerve growth factor (NGF) in the serum of a patient with medullary carcinoma of the thyroid gland, Thyroid Research, (1976)

← 1 2 →